Corbus Pharmaceuticals Holdings, Inc. (CRBP) Social Stream



Corbus Pharmaceuticals Holdings, Inc. (CRBP): $6.90

0.51 (+7.98%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRBP to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

CORBUS PHARMACEUTICALS HOLDINGS INC (CRBP) Price Targets From Analysts

Use the tables below to see what analysts covering CORBUS PHARMACEUTICALS HOLDINGS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-15 4 $3 $1.4 $2.063 $6.2 -66.73%
2021-11-15 3 $3 $1.4 $2.2 $6.2 -64.52%
2022-11-09 3 $3 $3 $3 $6.2 -51.61%
2023-02-13 3 $120.12 $90.09 $105.105 $6.2 1595.24%
2023-03-08 3 $120.12 $3 $61.56 $6.2 892.9%

The Trend in the Analyst Price Target


CRBP's average price target has moved up $59.58 over the prior 52 weeks.

Over the past 43 weeks, CRBP's average upside potential has been 19,486.48%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-12 3 3.00 0.96 1.980 0.210 842.86%
2022-11-09 3 3.00 0.96 1.980 0.125 1484%
2022-11-09 3 3.00 3.00 3.000 0.125 2300%
2023-02-13 3 120.12 90.09 105.105 4.269 2362.05%
2023-03-08 3 120.12 3.00 61.560 2.520 2342.86%

CRBP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 1 0 2 0 0 3

The Trend in the Broker Recommendations


CRBP's average broker recommendation rating improved by 0 over the prior 30 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRBP as an investment opportunity.

  • In terms of how CORBUS PHARMACEUTICALS HOLDINGS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 291.81% of that group.
  • In the context of stocks in the small market cap category, CORBUS PHARMACEUTICALS HOLDINGS INC's average analyst price target is higher than 300.04% of them.
  • In the context of Healthcare stocks, CORBUS PHARMACEUTICALS HOLDINGS INC's number of analysts covering the stock is higher than 81.43% of them.
  • In the context of stocks in the small market cap category, CORBUS PHARMACEUTICALS HOLDINGS INC's variance in analysts' estimates is lower than -344.7% of them.

In the Pharmaceutical Products industry, NERV, EGRX, and PLXP are the three stocks most similar to CORBUS PHARMACEUTICALS HOLDINGS INC regarding the price target and analyst recommendation information presented here.

Is CRBP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7784 seconds.